Erawat Pharma Limited - Due diligence report

A 360° intelligence report on Erawat Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress …

1993-03-01 Indore, Madhya Pradesh Active Unlisted Active Compliant
Share
EP Erawat Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Erawat Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Erawat Pharma Limited is assessed as Low Risk with a Trust Score of 81/100. Erawat Pharma Limited is an active public limited indian non-government company incorporated in 1993, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 18 Jul 2026 from the latest processed filings. Erawat Pharma Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
73/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Profitable - internal accruals available.
  • Externally credit-rated (BB).

Charges position: 15 open (50.00 cr) · 10 satisfied (29.78 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others16 48.0 cr
Bank Of India3 48.0 cr
Yes Bank Limited2 48.0 cr
Industrial Development Bank Of India1 48.0 cr
Export-Import Bank Of India1 48.0 cr
Sidbi2 48.0 cr
Compliance Score: 73/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • Delayed payments to MSME suppliers disclosed (31 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
AMIT JAIN 01234567 Director 01/04/2018 6 yrs Approved
VASANT RAJ SOLANKI 01234567 Director 01/04/2018 6 yrs Approved
DEVINDAR SINGH SODHI 01234567 Director 01/04/2018 6 yrs Approved
HEMCHANDRA JAIN 01234567 Director 01/04/2018 6 yrs Approved
ABHIJEET JAIN 01234567 Director 01/04/2018 6 yrs Approved
ABHISHEK JAIN 01234567 Director 01/04/2018 6 yrs Approved
MEENA JAIN 01234567 Director 01/04/2018 6 yrs Approved
  • 7 directors on the board.
  • VASANT RAJ SOLANKI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: AMIT JAIN (Whole-time director) · HEMCHANDRA JAIN (Managing Director) · ABHIJEET JAIN (Whole-time director) · ABHISHEK JAIN (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Asset base grew 24% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 33+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
15 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 1.09 cr.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence80/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 15 open charge(s) of 50.00 cr already registered.
  • Compliance record supports lending.
Investor view84/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
20 Nov 2024
Charge created
Sidbi - 81.76 Lakh
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
26 Feb 2024
Charge created
Others - 89.08 Lakh
22 Nov 2023
Charge created
Sidbi - 1.28 cr
13 Apr 2023
Charge created
Others - 8.24 cr
21 Oct 2022
Charge created
Others - 6.00 cr
Charge created
Others - 69.30 Lakh
Charge created
Others - 42.70 Lakh
02 Aug 2022
Charge created
Others - 6.00 cr
30 Apr 2022
Charge created
Others - 69.30 Lakh
Charge created
Others - 42.70 Lakh
14 Jan 2022
Charge created
Others - 41.00 Lakh
21 Dec 2021
Charge satisfied
Bank Of India
15 Dec 2021
Charge satisfied
Others
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
7 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of BB from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sriam U24239AP2002PTC121365 Yadadri Bhuvanagiri District, Telangana, India
Airlife Gases Private Limited U74999PN2019PTC183575 Pune City, Maharashtra, India
Shanpar Industries Private Limited U24110GJ2005PTC045542 Vadodara, Gujarat, India
Island Veer Chemie Pvt Ltd U24110TG1993PTC016526 Hyderabad, Telangana, India
Wanksons Chemicals Industries Private Limited U24200MH1989PTC052414 Mumbai, Maharashtra, India
Electrochem Technologies India Private Limited U52390TN2012PTC088995 Chennai, Tamil Nadu, India
Acro Paints U24119UP1989PLC195992 Kanpur, Uttar Pradesh, India
Sauradip Chemical Industries Pvt Ltd U24110MH1986PTC039133 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Erawat Pharma Limited before audits and certifications: compliance score 73/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Erawat Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Erawat Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Erawat Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Erawat Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Erawat Pharma Limited an active company?

Erawat Pharma Limited has MCA status “Active” with a compliance score of 73/100 (Moderate).

Is Erawat Pharma Limited financially healthy?

Erawat Pharma Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Erawat Pharma Limited?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Erawat Pharma Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 7 active director(s) are on record.

Does Erawat Pharma Limited have loans or charges against its assets?

15 open charge(s) are registered against its assets, and 10 earlier charge(s) stand satisfied.

Is Erawat Pharma Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 73/100 (Moderate).

Is it risky to lend to Erawat Pharma Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.